We designed a delivery vehicle that locally maintains recombinant human bone morphogenetic protein-2 (rhBMP-2) at bone surgery sites to enhance bone healing while minimizing excessive bone formation at non-targeted sites.
Kim et al. (Thu,) studied this question.